← Back to Trial

A Clinical Trial Evaluating the Safety of TD001 In Patients With PSMA-Expressing Metastatic Prostate Cancer

Trial Locations

• Yale University, Yale Cancer Center New Haven, Connecticut, United States
  • Contact: TOAD Clinical Operations · 41 41 556 64 01 · [email protected] (opens in new tab)
• Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
  • Contact: TOAD Clinical Operations · 41 41 556 64 01 · [email protected] (opens in new tab)
• Princess Margaret Cancer Centre Toronto, Ontario, Canada
  • Contact: TOAD Clinical Operations · 41 41 556 64 01 · [email protected] (opens in new tab)
• Institut Bergonié Bordeaux, France
  • Contact: TOAD Clinical Operations · 41 41 556 64 01 · [email protected] (opens in new tab)
• Hôpital Paris Saint Joseph Paris, France
  • Contact: TOAD Clinical Operations · 41 41 556 64 01 · [email protected] (opens in new tab)
• Institut Gustave Roussy Villejuif, France
  • Contact: TOAD Clinical Operations · 41 41 556 64 01 · [email protected] (opens in new tab)
• Vall d'Hebron Institute of Oncology Barcelona, Spain
  • Contact: TOAD Clinical Operations · 41 41 556 64 01 · [email protected] (opens in new tab)